vimarsana.com

Page 121 - ஃப்ரெட் ஹட்சின்சன் புற்றுநோய் ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

20 Under 40: Young Shapers of the Future (Health and Medicine)

Courtesy of Audrey L. Blewer Audrey Blewer had an early interest in history, concentrating on Latin America at the University of Florida in Gainesville. Along the way, though, she took an interest in public health and switched to that discipline for her master’s degree at the school, studying the health of imprisoned women. She went on to earn a Ph.D. in epidemiology at the University of Pennsylvania. She is now an assistant professor of family medicine and community health at Duke University School of Medicine. Her recent studies in cardiopulmonary resuscitation (CPR) incidents, the subject of her dissertation, have shown that women receive it less often than men, leading to the development of a CPR dummy with breasts for professional and civilian training. Her further studies suggest that CPR training dissemination strategies can be expanded and better fitted to address geographic, racial, and socioeconomic disparities in CPR education and delivery, especially at the hands of ci

Antibody Mediated Prevention (AMP) trials data published by the i New England Journal of Medicine /i

Antibody Mediated Prevention (AMP) trials data published by the New England Journal of Medicine Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains Public Relations Pacific LLC  E-Mail SEATTLE - (EMBARGOED UNTIL MARCH 17, 2021, AT 5 P.M. ET) - The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This finding was seen both in Sub-Saharan Africa and the U.S. and South America. VRCO1 did not prevent the acquisition of HIV to strains that were resistant to the bNAb. As the resistant strains constituted nearly 70% of the circulating strains in these regions, there was no difference noted between the VRC01 arms and placebo arm in terms of overall prevention of HIV acquisition. The sensitivity to bNAbs was assessed by a laborat

Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial

Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.